Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
that one has 38 mill float... i like these 1 mill loats tiny as share os
rdva spread quite big, rscf reported revenue increasing, looking into whether dilution etc but it seems great..
Seems like a great one, also saw rscf and looking into both, modrna et al will soon need all these as they would want to keep costs low so might use these companies etc.
Just heard about this one 10mill as 5 os 1 mill float real comapny
pinker but they do alot of refridgerating for drug companies
under radar still dirt cheap
symbol is RDVA. Big bids coming in
yeah its makin top ticks and white carries his bags..lol
i might have a real refridge company otcbb under radar .. will hit u soon after my dd
$LTMP: A nice big surge like $TZPC..............
Ready to go down.
That went from $0.05 to $5 last week.
$LTMP getting ready to do the same.
GO $LTMP
$LTMP: Moderna gonna have 40Million vaccines
By end of December according to CEO this morning.
Gotta keep them cool.
$LTMP got what it takes.... maybe a supply contract with FedEx & UPS
GO $LTMP
$LTMP refrigerant sales will go bonkers>>>
Moderna's Vaccine approved............ Requires Refrigeration
Thanks makinezmoney
Moderna Announces Longer Shelf Life for its COVID-19 Vaccine Candidate at Refrigerated Temperatures MRNA
****************************************************
Vaccine candidate now expected to remain stable at standard refrigerator temperatures of 2deg to 8degC (36deg to 46degF) for 30 days, up from previous estimate of 7 days
Shipping and long-term storage conditions at standard freezer temperatures of -20degC (-4degF) for 6 months
mRNA-1273 to be distributed using widely available vaccine delivery and storage infrastructure
No dilution required prior to vaccination
CAMBRIDGE, Mass.--(BUSINESS WIRE)--November 16, 2020--
Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced new data showing that mRNA-1273, its COVID-19 vaccine candidate, remains stable at 2deg to 8degC (36deg to 46degF), the temperature of a standard home or medical refrigerator, for 30 days. Stability testing supports this extension from an earlier estimate of 7 days. mRNA-1273 remains stable at -20deg C (-4degF) for up to six months, at refrigerated conditions for up to 30 days and at room temperature for up to 12 hours.
"We believe that our investments in mRNA delivery technology and manufacturing process development will allow us to store and ship our COVID-19 vaccine candidate at temperatures commonly found in readily available pharmaceutical freezers and refrigerators," said Juan Andres, Chief Technical Operations and Quality Officer at Moderna. "We are pleased to submit these extended stability conditions for mRNA-1273 to regulators for approval. The ability to store our vaccine for up to 6 months at -20deg C including up to 30 days at normal refrigerator conditions after thawing is an important development and would enable simpler distribution and more flexibility to facilitate wider-scale vaccination in the United States and other parts of the world."
Shipping & Long-term Storage: For shipping and longer-term storage, Moderna expects that mRNA-1273 will be maintained at -20degC (-4degF), equal to most home or medical freezer temperatures, for up to 6 months. Using standard freezer temperatures of -20degC (range of -25deg to -15degC or -13deg to 5degF) is an easier and more established method of distribution and storage than deep freezing and most pharmaceutical distribution companies have the capability to store and ship products at -20degC (-4degF) worldwide.
Refrigeration Storage: After thawing, to facilitate storage at points of administration, Moderna expects that mRNA-1273 will remain stable at standard refrigerated conditions of 2deg to 8degC (36deg to 46degF) for up to 30 days within the 6-month shelf life. The stability at refrigerated conditions allows for storage at most pharmacies, hospitals, or physicians' offices.
Room Temperature for Vaccination: Once the vaccine is removed from the refrigerator for administration, it can be kept at room temperature conditions for up to 12 hours.
No Dilution Required at Vaccination Site: The vaccine will not require onsite dilution or special handling, which facilitates vaccination across a range of settings including pharmacies and physicians' offices.
The Company anticipates that it will continue to gather additional stability information over the coming months to assess whether mRNA-1273 can be shipped and stored under increasingly flexible conditions, which will be described in detail following regulatory approval.
The mRNA-1273 COVID-19 vaccine candidate is Moderna's tenth mRNA vaccine to enter the clinic. With its experience in prophylactic vaccine development and investments in mRNA platform and delivery technology, Moderna has developed enhanced manufacturing processes, resulting in proprietary lipid nanoparticle technology that Moderna believes will enable the vaccine to be stored at standard pharmaceutical distribution temperatures.
Moderna is working with the U.S. Centers for Disease Control and Prevention (CDC), Operation Warp Speed and McKesson (NYSE: MCK), a COVID-19 vaccine distributor contracted by the U.S. government, as well as global stakeholders to be prepared for distribution of mRNA-1273, in the event that it receives an Emergency Use Authorization and/or similar global authorizations. The Company is also working closely with the U.S. Food and Drug Administration (FDA) to submit data from its ongoing stability testing for approval.
About mRNA-1273
mRNA-1273 is an mRNA vaccine against COVID-19 encoding for a prefusion stabilized form of the Spike (S) protein, which was co-developed by Moderna and investigators from NIAID's Vaccine Research Center. The first clinical batch, which was funded by the Coalition for Epidemic Preparedness Innovations, was completed on February 7, 2020 and underwent analytical testing; it was shipped to the NIH on February 24, 42 days from sequence selection. The first participant in the NIAID-led Phase 1 study of mRNA-1273 was dosed on March 16, 63 days from sequence selection to Phase 1 study dosing. On May 12, the FDA granted mRNA-1273 Fast Track designation. On May 29, the first participants in each age cohort: adults ages 18-55 years (n=300) and older adults ages 55 years and above (n=300) were dosed in the Phase 2 study of mRNA-1273. On July 8, the Phase 2 study completed enrollment.
Results from the second interim analysis of the NIH-led Phase 1 study of mRNA-1273 in the 56-70 and 71+ age groups were published on September 29 in The New England Journal of Medicine. On July 28, results from a non-human primate preclinical viral challenge study evaluating mRNA-1273 were published in The New England Journal of Medicine. On July 14, an interim analysis of the original cohorts in the NIH-led Phase 1 study of mRNA-1273 was published in The New England Journal of Medicine. mRNA-1273 currently is not approved for use by any regulatory body.
BARDA is supporting the continued research and development of mRNA-1273 with $955 million in federal funding under Contract no. 75A50120C00034. BARDA is reimbursing Moderna for 100 percent of the allowable costs incurred by the Company for conducting the program described in the BARDA contract. The U.S. government has agreed to provide up to $1.525 billion to purchase supply of mRNA-1273 under U.S. Department of Defense Contract No. W911QY-20-C-0100.
Forward Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including regarding the Company's development of a potential vaccine (mRNA-1273) against the novel coronavirus, the conditions under which mRNA-1273 can be shipped, stored and administered, and the U.S. government's potential purchases of mRNA-1273. In some cases, forward-looking statements can be identified by terminology such as "will," "may," "should," "could", "expects," "intends," "plans," "aims," "anticipates," "believes," "estimates," "predicts," "potential," "continue," or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. The forward-looking statements in this press release are neither promises nor guarantees, and you should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties, and other factors, many of which are beyond Moderna's control and which could cause actual results to differ materially from those expressed or implied by these forward-looking statements. These risks, uncertainties, and other factors include, among others: the fact that there has never been a commercial product utilizing mRNA technology approved for use; the fact that the rapid response technology in use by Moderna is still being developed and implemented; the fact that the safety and efficacy of mRNA-1273 has not yet been established; despite having ongoing interactions with the FDA or other regulatory agencies, the FDA or such other regulatory agencies may not agree with the Company's regulatory approval strategies, components of our filings, such as clinical trial designs, conduct and methodologies, or the sufficiency of data submitted; potential adverse impacts due to the global COVID-19 pandemic such as delays in regulatory review, manufacturing and clinical trials, supply chain interruptions, adverse effects on healthcare systems and disruption of the global economy; and those other risks and uncertainties described under the heading "Risk Factors" in Moderna's most recent Quarterly Report on Form 10-Q filed with the U.S. Securities and Exchange Commission (SEC) and in subsequent filings made by Moderna with the SEC, which are available on the SEC's website at www.sec.gov. Except as required by law, Moderna disclaims any intention or responsibility for updating or revising any forward-looking statements contained in this press release in the event of new information, future developments or otherwise. These forward-looking statements are based on Moderna's current expectations and speak only as of the date hereof.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201116005606/en/
CONTACT: Moderna Contacts
Media:
Colleen Hussey
Director, Corporate Communications
617-335-1374
Colleen.Hussey@modernatx.com
Investors:
Lavina Talukdar
Senior Vice President & Head of Investor Relations
617-209-5834
Lavina.Talukdar@modernatx.com
SOURCE: Moderna, Inc.
Copyright Business Wire 2020
> Dow Jones Newswires
November 16, 2020 06:52 ET (11:52 GMT)
InvestorsHub NewsWire
this for real or pump?
looks interesting. freeze shipping hot
And, THANKS again, 'WH-JR'!!
Alltemp supplies refrigeration fluids >>> the demand during Operation Vaccine worldwide will be insane
Off website>>>COMMERCIAL REFRIGERATION
This new generation of products offers an optimal solution for all stationary applications, including retail food, transport, industrial and many more.
go $LTMP
Looks like I'm not the only one following 'EZ-$$' like a wake follows a ship across the ocean!!
THANKS!! For that DD, 'WH-Jr'!!! (Working on my best OTC grab for this looming Monday! I follow the iHub Pundits, like YOU! Since I don't know 'Shut-From-Shinola' about this stuff, I need YOU guys!!)
Good reads about the gargantuan effort $LTMP could be a part of
https://www.google.com/amp/s/www.nytimes.com/2020/09/18/business/coronavirus-covid-vaccine-cold-frozen-logistics.amp.html
https://www.google.com/amp/s/www.nytimes.com/2020/11/14/health/covid-vaccine-distribution-plans.amp.html
the vaccine's complex and super-cold storage requirements are an obstacle for even the most sophisticated hospitals in the United States and may impact when and where it is available in rural areas or poor countries where resources are tight.
The main issue is that the vaccine, which is based on a novel technology that uses synthetic mRNA to activate the immune system against the virus, needs to be kept at minus 70 degrees Celsius (-94 F) or below.
"The cold chain is going to be one of the most challenging aspects of delivery of this vaccination," said Amesh Adalja, senior scholar at Johns Hopkins Center for Health Security.
"This will be a challenge in all settings because hospitals even in big cities do not have storage facilities for a vaccine at that ultra-low temperature."
“Delivering billions of doses of vaccine which must be kept at ultra cold temperatures to the entire world efficiently will involve hugely complex logistical and programmatic obstacles all the way along the supply chain. We look forward to working together with government, vaccine manufacturers and logistical partners to ensure an efficient global roll-out of a safe and affordable COVID-19 vaccine,” said Dr Seth Berkley, CEO of Gavi, the Vaccine Alliance.
Facilities: Vaccines must be handled and transported in line with international regulatory requirements, at controlled temperatures and without delay to ensure the quality of the product. While there are still many unknowns (number of doses, temperature sensitivities, manufacturing locations, etc.), it is clear that the scale of activity will be vast, that cold chain facilities will be required and that delivery to every corner of the planet will be needed. Priorities for preparing facilities for this distribution include:
Availability of temperature-controlled facilities and equipment - maximizing the use or re-purposing of existing infrastructure and minimizing temporary builds
Availability of staff trained to handle time- and temperature-sensitive vaccines
Robust monitoring capabilities to ensure the integrity of the vaccines is maintained
Security: Vaccines will be highly valuable commodities. Arrangements must be in place to keep ensure that shipments remain secure from tampering and theft. Processes are in place to keep cargo shipments secure, but the potential volume of vaccine shipments will need early planning to ensure that they are scalable.
Border Processes: Working effectively with health and customs authorities will, therefore, be essential to ensure timely regulatory approvals, adequate security measures, appropriate handling and customs clearance. This could be a particular challenge given that, as part of COVID-19 prevention measures, many governments have put in place measures that increase processing times. Priorities for border processes include:
Introducing fast-track procedures for overflight and landing permits for operations carrying the COVID-19 vaccine
Exempting flight crew members from quarantine requirements to ensure cargo supply chains are maintained
Supporting temporary traffic rights for operations carrying the COVID-19 vaccines where restrictions may apply
Removing operating hour curfews for flights carrying the vaccine to facilitate the most flexible global network operations
Granting priority on arrival of those vital shipments to prevent possible temperature excursions due to delays
Considering tariff relief to facilitate the movement of the vaccine
Capacity
On top of the transport preparations and coordination needed, governments must also consider the current diminished cargo capacity of the global air transport industry. IATA warned that, with the severe downturn in passenger traffic, airlines have downsized networks and put many aircraft into remote long-term storage. The global route network has been reduced dramatically from the pre-COVID 24,000 city pairs. The WHO, UNICEF and Gavi have already reported severe difficulties in maintaining their planned vaccine programs during the COVID-19 crisis due, in part, to limited air connectivity.
“The whole world is eagerly awaiting a safe COVID vaccine. It is incumbent on all of us to make sure that all countries have safe, fast and equitable access to the initial doses when they are available. As the lead agency for the procurement and supply of the COVID vaccine on behalf of the COVAX Facility, UNICEF will be leading what could possibly be the world’s largest and fastest operation ever. The role of airlines and international transport companies will be critical to this endeavour,” said Henrietta Fore, UNICEF Executive Director.
The potential size of the delivery is enormous. Just providing a single dose to 7.8 billion people would fill 8,000 747 cargo aircraft. Land transport will help, especially in developed economies with local manufacturing capacity. But vaccines cannot be delivered globally without the significant use air cargo.
“Even if we assume that half the needed vaccines can be transported by land, the air cargo industry will still face its largest single transport challenge ever. In planning their vaccine programs, particularly in the developing world, governments must take very careful consideration of the limited air cargo capacity that is available at the moment. If borders remain closed, travel curtailed, fleets grounded and employees furloughed, the capacity to deliver life-saving vaccines will be very much compromised,” said de Juniac.
That’s why I follow you >> one of the few in otc that knows what the heck there doing!! Looking forward to this barn burner running its butt off to $1.00 $LTMP
$LTMP: There aren't any...... MM's are just holding
a wall up..... fake as it is.
They got caught redhanded with TZPC and look how far it pushed them.
when it breaks down and they catchup to it, they will be alerted and
will have to switch positions........ because they are on the wrong end of the trade then and could be in jeapordy with a strong run
thats how you fix em up
GO $LTMP
If they were a sellers they would have hit me by now $LTMP
$LTMP: They can try to prevent a run...........
but fake ask walls won't work for them forever.
and they know it, hence the futile resistance
$0.024 is still way better a starting point than where it will be.
GO $LTMP
I’ve had a partial order in at 23 for hours >>> ask not budging
$LTMP: Thats a dangerous strategy........
CUz those $0.02s can be cleared out sooooooooooooooooooo fast that shorts heads are gonna turn
GO $LTMP
I think the bidder at 15 is also parked at 24 to try to encourage sells to bid... tick tock $LTMP
$LTMP : Somebody bidding $15k at $0.015
They want in ........ question is, how badly they want in.
Nows the time to make the ask rocket so it runs hard like $TZPC
GO $LTMP
Someone steal that 200k let’s get going!! $LTMP
Great find! Like your other>>>I did and I had a bid in but it never took...guess I should have hit .15 lol oh you know how that story plays out ...lol
$LTMP
$LTMP: We should be at $1 by end of MONTH
YOu saw my prediction on $TZPC......... played out perfectly.
THis puppy is NEXT !
Followers will catch on later........... when its already run super hard.
GO $LTMP
$LTMP : Who else would they choose ?
What other options do they have for refrigeration ?
Also, this is a worldwide thing........... AllTEMP is now approved for INDIA as well.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149963647
What are the number of covid cases in INDIA right now ???????
YOu saw TZPC run like a ma'fukka today......... guess who's next.
Still undiscovered here. I'm already in for 100k
GO $LTMP
Why would they choose LVMP for the job?
$LTMP: FedEx ready to deliver Vaccines..............
What are they gonna use ?????????
https://www.fox13memphis.com/news/local/fedex-set-deliver-covid-19-vaccines-worldwide/TV36LZTUQZDWJOEY3LCCE2O27Q/
GO $LTMP
$LTMP Carrier & UPS with FreezerFarms for Covid-VACCINE
Guess who supplies refrigerant ??????????
You just saw what TZPC did.......... guess who's next ?
GO $LTMP
$LTMP: Full refrigeration catalogue
alltemp.ca/wp-content/files_mf/1337786510ATP2004.pdf
Now at $0.02
GO $LTMP
$LTMP: You just saw $TZPC run hard....... cooling vaccines
Guess who else is in that space.............
https://alltempsolutions.com/#:~:text=alltemp%C2%AE%20reduces%20energy%20consumption,off%20once%20leaks%20are%20repaired.
GO $LTMP
$LTMP : Approved by Government of INDIA
Government of India Issues Approval for Incorporation of Alltemp Sustainable Refrigerants of India Private Limited
9:03 AM ET 7/17/19 | BusinessWire
Related Quotes
1:17 PM ET 7/16/19
Symbol Last % Chg
LTMP
0.05 0.00%
Real time quote.
WESTLAKE VILLAGE, Calif.--(BUSINESS WIRE)--July 17, 2019--
Alltemp, Inc. (OTCPK: LTMP), a manufacturer of proprietary, environment-friendly refrigerants designed to deliver significant energy and financial savings, announced the approval by the Government of India for the establishment of its India entity, "Alltemp Sustainable Refrigerants India Private Limited.".Alltemp's India entity received its Certificate of Incorporation, dated June 10(th) , 2019, from India's Ministry of Corporate Affairs.
The establishment of an India corporation opens the door for Alltemp, Inc. to more efficiently deliver its energy saving proprietary alltemp(R) refrigerants for the massive India market and surrounding region. Alltemp has worked over the past 18 months to establish relationships and prove the value of its products in this region of the world while deepening its understanding of the significant need and market. With this entity formally established, Alltemp plans to substantially accelerate its business plans for sales in this region. Additional developments related to India are expected to be communicated soon.
On May 15, 2019, an updated research report issued by ResearchandMarkets.com noted that, "the India HVAC market is expected to attain a size of $5.9 billion by 2024, progressing at a CAGR of 7% during the forecast period (2019-2024). The major factors driving the growth of the market are increasing number of high-rise buildings, hypermarkets in Tier-II cities, and shopping complexes and malls, where HVAC systems are an essential requirement. Furthermore, the market is predicted to progress due to the on-going smart city projects in the nation." See news at: https://www.businesswire.com/news/home/20190515005493/en/Indias-HVAC-Market-2019-Size-Share-Development
Alltemp, Inc. CEO Bill Lopshire stated, "India is one of the largest markets in the world for our refrigerants. Based on our relationships and sales projections with existing interested parties, this opportunity alone has the capability to deliver positive net income to Alltemp over the next six to nine months."
About Alltemp, Inc.
Alltemp, Inc. has developed a proprietary refrigerant technology, after years of research and development, called alltemp(R), a proven replacement for many worldwide refrigerants that have detrimentally affected the global environment. Alltemp(R) refrigerants are environmentally friendly, sustainable, and cost-efficient energy solutions for the residential and commercial marketplace. Alltemp refrigerants have broad applications, ranging from Heating Ventilation and Air Conditioning ("HVAC"), to refrigeration and foam insulation, to industrial solvents. Alltemp is the ideal solution for replacement R-134a, R-404a, and HCFC-22, better known as R-22, but which is rapidly being phased out in all developed countries due to environmental concerns over its strong effect on the depletion of the Earth's ozone layer. For further information, please go to alltempsolutions.com.
Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning of The Private Securities Litigation Reform Act of 1995 (the "Act"), as well as Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. In particular, when used in the proceeding discussion, the words "plan," "confident that," "believe, " "expect," or "intend to," and similar conditional expressions are intended to identify forward-looking statements within the meaning of the Act and are subject to the safe harbor created by the Act. Such statements about the Company's future expectations, including future revenues and earnings, and all other forward-looking statements are subject to certain risks and uncertainties that are subject to change at any time, and the Company's actual results could differ materially from those expressed in any of the forward-looking statements. Such risks and uncertainties include, but are not limited to, market conditions, the availability of components for and delays in the start of production, general acceptance of the Company's products and technologies, competitive factors, the ability to successfully complete additional financing, and other risks.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190717005451/en/
CONTACT: Ben Hansel
(720) 288-8495
SOURCE: Alltemp, Inc.
Copyright Business Wire 2019
> Dow Jones Newswires
July 17, 2019 09:03 ET (13:03 GMT)
What a POS this is. Another typical pink sheet nothing .
Loaded up on this. May be coming alive again.
Love this bottomed out Nasdaq ticker (-;
North Park Innovations Updates iManifold(R) System with Alltemp Refrigerant Parameters
Alltemp Teams Up with NPI, Improving the Installation Process for Thousands of Technicians in 19 Countries on the iManifold Network
WESTLAKE VILLAGE, CA / ACCESSWIRE / September 26, 2017 / Alltemp, Inc. (LTMP) (the "Company"), a developer of proprietary, environmentally friendly refrigerant technologies, announced today that the Company's alltemp® refrigerant data has been added to the iManifold system interface.
This move pairs two HVAC technology innovators by bringing these advancements to the global industry. The interface will soon allow alltemp® users to get the most out of their alltemp® refrigerant and their climate control systems. Better installs result in even more efficiently running systems, which translate into greater user savings.
iManifold is scheduling an Alltemp specific data update, which will be sent to thousands of technicians on its user network, in 19 countries in October of 2017.
The iManifold platform is a revolutionary, patented digital technology designed to make HVAC technicians more efficient. This system allows HVAC technicians to read data and diagnose system issues accurately and quickly, and comes with a free app that includes basic reporting. Additional advanced reporting and other features are offered with the iManifold cloud subscription, providing easy sharing, better connectivity, and field technical support with Tech-Connect™. The iManifold has won numerous industry awards and is used in HVAC equipment commissioning by several global OEMs.
"iManifold's digital technology is able to provide additional support to make installation of our alltemp® refrigerants even more seamless. Among its many client-specific features is the ability to showcase an HVAC system's before and after performance," said William Lopshire, Alltemp CEO.
"We are honored to have Alltemp, Inc. select our iManifold platform to be the preferred technology for installation and verification of their innovative refrigerant products," said Bill Northrup, North Park Innovations Group CEO.
For alltemp® inquiries, please contact Mark Greenberg at (855) 687-4867, ext. 712 or mark@alltemp.solutions.
About iManifold
North Park Innovations Group's revolutionary, patented product is the first smart device (iPhone, iPad, and Android) compatible wireless refrigeration diagnostic platform. The iManifold displays the system's actual pressures, temperatures, superheat and subcooling while simultaneously calculating performance targets. The color display provides a visual indication of distance from target measurement, eliminating guesswork. In addition to ensuring peak performance after installation or service, the iManifold's software platform allows remote streaming and support based on the readings on a technician's smart device, thereby saving travel time and money. For further information, please go to www.iManifold.com.
About Alltemp, Inc.
Alltemp, Inc. has developed a proprietary refrigerant technology, after years of research and development, called alltemp®, a proven replacement for many worldwide refrigerants that have detrimentally affected the global environment. Alltemp's refrigerants are environmentally friendly, sustainable, and cost-efficient energy solutions for the residential and commercial marketplace. alltemp® refrigerants have broad applications, ranging from Heating Ventilation and Air Conditioning ("HVAC") to refrigeration and foam insulation, to industrial solvents. alltemp® is the ideal solution for replacement of R-407c, R-134a, R-404a, and HCFC-22, better known as R-22, but which is rapidly being phased out in all developed countries due to environmental concerns over its strong effect on the depletion of the Earth's ozone layer. For further information, please go to alltempsolutions.com.
Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning of The Private Securities Litigation Reform Act of 1995 (the "Act"), as well as Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. In particular, when used in the proceeding discussion, the words "plan," "confident that," "believe," "expect," or "intend to," and similar conditional expressions are intended to identify forward-looking statements within the meaning of the Act and are subject to the safe harbor created by the Act. Such statements about the Company's future expectations, including future revenues and earnings, and all other forward-looking statements are subject to certain risks and uncertainties that are subject to change at any time, and the Company's actual results could differ materially from those expressed in any of the forward-looking statements. Such risks and uncertainties include, but are not limited to, market conditions, the availability of components for and delays in the start of production, general acceptance of the Company's products and technologies, competitive factors, the ability to successfully complete additional financing, and other risks.
https://finance.yahoo.com/news/north-park-innovations-updates-imanifold-120500881.html
Alltemp Partners with Trinity to Offer Comprehensive Extended Warranty Coverage
Alltemp's Energy-saving Refrigerant Can Now be Paired with Trinity's Strongest Warranty Programs
WESTLAKE VILLAGE, CA / ACCESSWIRE / September 21, 2017 / Alltemp, Inc. (LTMP) (the "Company"), a developer of proprietary, environmentally friendly refrigerant technologies, announced today that the Company is now able to offer a strong third-party extended warranty (ESA), for clients' HVAC systems that are running alltemp refrigerants, backed by Trinity Warranty.
Manufacturer warranties usually cover parts, but they often do not cover labor, even in the first year, and most do not cover the equipment for up to 5 or 10 years. Trinity Warranty understands that partnering with original equipment manufacturers (OEMs) requires full knowledge of the needs of the distribution channel. Trinity's goal is to design warranty products that meet consumer needs while providing the OEM with an attractive program that's easy to administer.
The extended warranty plan is available to most alltemp users and can enhance the manufacturer's warranty, with an option for up to a 10-year extension that can also include parts and labor. The adoption of the plan reinforces Alltemp's commitment to providing the highest-quality service available. For details on the Trinity Warranty extended warranty (ESA), please visit www.trinitywarranty.com.
"We believe that we designed alltemp to be the best refrigerant on the market and we are now backing it up with the best-extended service agreements available. In addition to making this commitment to Alltemp's clients, this new extended warranty is a reflection of alltemp's performance and benefits, which include improving HVAC systems' reliability, so adopting Trinity Warranty's extended service agreements will become another potent tool that enhances our ability to provide exceptional quality of service, peace of mind, and lower costs to our clients' bottom lines. In short, implementing this program aims to boost confidence in Alltemp's products with the backing of one the industry's most comprehensive HVAC systems extended warranties," said William Lopshire, Alltemp CEO.
For alltemp® sales inquiries, please contact Mark Greenberg at (855) 687-4867, ext 712 or mark@alltemp.solutions.
About Trinity Warranty
Trinity Warranty is a recognized leader in Extended Service Agreement (ESA) products and services. It provides risk management solutions to HVAC/R industry manufacturers, distributors, dealers and consumers. Trinity products lengthen the term of protection on a major purchase and have a significant positive impact on the sales process from Distributor, to Dealer, to the Consumer. To learn more, visit www.trinitywarranty.com.
About Alltemp, Inc.
Alltemp, Inc. has developed a proprietary refrigerant technology, after years of research and development, called alltemp®, a proven replacement for many worldwide refrigerants that have detrimentally affected the global environment. alltemp®'s refrigerants are environmentally friendly, sustainable, and cost-efficient energy solutions for the residential and commercial marketplace. alltemp® refrigerants have broad applications, ranging from Heating Ventilation and Air Conditioning ("HVAC"), to refrigeration and foam insulation, to industrial solvents. alltemp® is the ideal solution for replacement of R-407c, R-134a, R-404a, and HCFC-22, better known as R-22, but which is rapidly being phased out in all developed countries due to environmental concerns over its strong effect on the depletion of the Earth's ozone layer. For further information, please go to alltempsolutions.com.
Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning of The Private Securities Litigation Reform Act of 1995 (the "Act"), as well as Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. In particular, when used in the proceeding discussion, the words "plan," "confident that," "believe," "expect," or "intend to," and similar conditional expressions are intended to identify forward-looking statements within the meaning of the Act and are subject to the safe harbor created by the Act. Such statements about the Company's future expectations, including future revenues and earnings, and all other forward-looking statements are subject to certain risks and uncertainties that are subject to change at any time, and the Company's actual results could differ materially from those expressed in any of the forward-looking statements. Such risks and uncertainties include, but are not limited to, market conditions, the availability of components for and delays in the start of production, general acceptance of the Company's products and technologies, competitive factors, the ability to successfully complete additional financing, and other risks.
https://finance.yahoo.com/news/alltemp-partners-trinity-offer-comprehensive-120500459.html
Alltemp Enters into Strategic Partnership with Key Public Policy Relations Agency, Strategies 360
Strategic Partnership Integrates Alltemp's Traditional Marketing Efforts with a Leading Public Policy Team
WESTLAKE VILLAGE, CA / ACCESSWIRE / September 13, 2017 / Alltemp, Inc. (LTMP) (the "Company"), a developer of proprietary, environmentally friendly refrigerant technologies, announced today that Strategies 360 will serve as one of the Company's public policy relations agencies for its alltemp® refrigerant technologies.
The strategic partnership will focus on combining Alltemp's sales marketing effort with Strategies 360's influential business and political lobbying expertise. Strategies 360's footprint includes Hawaii, California, Oregon, Washington, Nevada and New York.
"A game-changer in the refrigerant world, Strategies 360 is proud to partner with Alltemp. Alltemp is the drop-in solution for office buildings and hospitals to schools and universities who want to fight climate change while saving money," stated David Richey, Strategies 360 Director of Communications and Public Policy.
"Strategies 360 is a leading public policy team and this assignment integrates our traditional marketing efforts with their legislative and communications' expertise, so this move will educate policymakers about our innovative and disruptive technology, as well as potentially place Alltemp ahead of the legislators' planning curve," said William Lopshire, Alltemp CEO.
For alltemp® inquiries, please contact Mark Greenberg at (855) 687-4867, ext 712 or mark@alltemp.solutions.
About Strategies 360
Strategies 360 redefined the best practices of public policy, business, strategic communications and marketing and blended them. By offering more services under one roof, Strategies 360 guarantees every client a seamless, tailored approach.
For further information, please go to www.strategies360.com.
About Alltemp, Inc.
Alltemp, Inc. has developed a proprietary refrigerant technology, after years of research and development, called alltemp®, a proven replacement for many worldwide refrigerants that have detrimentally affected the global environment. alltemp®,'s refrigerants are environmentally friendly, sustainable, and cost-efficient energy solutions for the residential and commercial marketplace. alltemp® refrigerants have broad applications, ranging from Heating Ventilation and Air Conditioning ("HVAC"), to refrigeration and foam insulation, to industrial solvents. alltemp® is the ideal solution for replacement of R-407c, R-134a, R-404a, and HCFC-22, better known as R-22, but which is rapidly being phased out in all developed countries due to environmental concerns over its strong effect on the depletion of the Earth's ozone layer. For further information, please go to www.alltempsolutions.com.
Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning of The Private Securities Litigation Reform Act of 1995 (the "Act"), as well as Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. In particular, when used in the proceeding discussion, the words "plan," "confident that," "believe," "expect," or "intend to," and similar conditional expressions are intended to identify forward-looking statements within the meaning of the Act and are subject to the safe harbor created by the Act. Such statements about the Company's future expectations, including future revenues and earnings, and all other forward-looking statements are subject to certain risks and uncertainties that are subject to change at any time, and the Company's actual results could differ materially from those expressed in any of the forward-looking statements. Such risks and uncertainties include, but are not limited to, market conditions, the availability of components for and delays in the start of production, general acceptance of the Company's products and technologies, competitive factors, the ability to successfully complete additional financing, and other risks.
Alltemp, Inc.
ir@stockcommgroup.com
832-802-8724
SOURCE: Alltemp, Inc.
https://finance.yahoo.com/news/alltemp-enters-strategic-partnership-key-120500206.html
Alltemp Reports Significant Chiller Energy Reduction in Field Test at Plastic Components, Inc.
alltemp® Ran 34% More Efficient than R-22 Refrigerant in Year-long Trial
WESTLAKE VILLAGE, CA / ACCESSWIRE / September 6, 2017 / Alltemp, Inc. (LTMP) (the "Company"), a developer of proprietary, environmentally friendly refrigerant technologies, announced today that the Company's alltemp® M refrigerant saved a large plastics molding company 34% of chiller energy consumption, through higher capacity and lower amps, when replacing R-22 refrigerant in a 25-ton chiller used for process cooling with measurement and verification services conducted by Stetz Consulting.
The chiller operates in a fully automated facility, which runs 24/7/365, and is key to allowing non-stop production of over 25,000,000 parts a month.
"Whenever we're able to reduce energy consumption and environmental degradation, it's a win for our client and their community," said William Lopshire, Alltemp CEO.
For alltemp® sales inquiries, please contact Hans Vollers at hans@alltemp.solutions or (855) 687-4867.
About Plastic Components
Plastic Components, Inc., founded in 1989 is a "fully-automated" molded plastics manufacturer with 2 facilities, totaling over 78,000 sq ft, shipping over 25,000,000 parts globally per month. For further information, please go to: plasticcomponents.com.
About Stetz Consulting
Stetz Consulting is the energy efficiency, renewable energy and carbon management consultancy firm of Mark Stetz, PE, CMVP, who has authored white papers, including Onset, on monitoring HVAC Performance and M&V for the Department of Energy. As a senior project manager for Nextant, he developed their M&V protocols.
About Alltemp, Inc.
Alltemp, Inc. has developed a proprietary refrigerant technology, after years of research and development, called alltemp®, a proven replacement for many worldwide refrigerants that have detrimentally affected the global environment. alltemp®,'s refrigerants are environmentally friendly, sustainable, and cost-efficient energy solutions for the residential and commercial marketplace. alltemp® refrigerants have broad applications, ranging from Heating Ventilation and Air Conditioning ("HVAC"), to refrigeration and foam insulation, to industrial solvents. alltemp® is the ideal solution for replacement of R-407c, R-134a, R-404a, and HCFC-22, better known as R-22, but which is rapidly being phased out in all developed countries due to environmental concerns over its strong effect on the depletion of the Earth's ozone layer. For further information, please go to alltempsolutions.com.
Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning of The Private Securities Litigation Reform Act of 1995 (the "Act"), as well as Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. In particular, when used in the proceeding discussion, the words "plan," "confident that," "believe," "expect," or "intend to," and similar conditional expressions are intended to identify forward-looking statements within the meaning of the Act and are subject to the safe harbor created by the Act. Such statements about the Company's future expectations, including future revenues and earnings, and all other forward-looking statements are subject to certain risks and uncertainties that are subject to change at any time, and the Company's actual results could differ materially from those expressed in any of the forward-looking statements. Such risks and uncertainties include, but are not limited to, market conditions, the availability of components for and delays in the start of production, general acceptance of the Company's products and technologies, competitive factors, the ability to successfully complete additional financing, and other risks.
Alltemp, Inc.
stan@stockcommgroup.com
ir@stockcommgroup.com
832-802-8724
SOURCE: Alltemp, Inc.
https://finance.yahoo.com/news/alltemp-reports-significant-chiller-energy-120500678.html
Five trends to improve Grocery Retailers
Retail grocery listings are still reeling from Amazon’s (NASDAQ: AMZN) plans to take over Whole Foods (NASDAQ: WFM), but let’s face it, with grocers already running paper-thin profit margins, it is the recently announced U.S. expansion plans for German hyper-efficient supermarkets Aldi and Lidl that had the grocery retailers already on edge. After all, online shopping isn’t new, with WalMart’s (NYSE: WMT) Jet, Kroger’s (NYSE: KR) HomeShop, and Costco’s (NASDAQ: COST) Shipt being just some of the current home grocery delivery options.
Unlike most industries, where online shopping is the norm, grocery shopping has been slow to change. Thus, despite the rapid growth rate, home delivery accounts for slightly more than 1% of the industry’s more than $700 billion in annual sales. It makes sense, because, whereas most consumers trust the pizza shop to deliver a consistent product, most shoppers don’t trust their own family members to pick out their produce.
The industry’s challenge is to implement new technologies and models to improve efficiencies and the broader shopping experience, as well as improve the company’s street cred. For example, to lower costs and reduce its carbon footprint, Wal-Mart began experimenting with solar energy panels and Bloom Energy’s “Bloom boxes,” which efficiently incorporate a cleaner electrochemical process to convert natural gas into electricity.
With that in mind, we’re going to look at five must-have technologies/trends that grocery retailers should incorporate.
Refrigerant
Grocers use more energy than other retailers because of their refrigeration demands, which remains one of their largest fixed costs. Alltemp (OTCB: LTMP) recently created a new refrigerant that maximizes performance via saving energy and increasing equipment life while protecting the environment; after testing in several Fortune 500 facilities, the refrigerant is now ready for market.
Refrigeration, air conditioning, and heat pumps account for about 10% of the global carbon emissions and energy consumption. Case studies confirm that Alltemp’s refrigerant significantly reduced the AMP draw to more than 40% from 10%. Alltemp’s test case at a McDonald’s restaurant location recorded a 23.7% kWh in refrigeration savings, while tests at 7Eleven, which more closely resembles the retail grocery model, reduced the refrigeration use by 38.16%.
Additionally, government regulations and rising R-22 prices were going to force millions of homeowners and business owners to replace their R-22-based air conditioners, creating a massive landfill nightmare and creating the financial burden of replacing decades’ worth of existing units. Plus, the energy savings are enough for some users to qualify for Energy Tax Credits.
Lighting
In many markets, daytime lighting costs can nearly be eliminated by incorporating solar lighting tubes, while LED lighting can go a long way to reducing lighting costs and improving the shopping experience.
Community hub
The general store at one point in time was the community hub of every American town; today’s grocers should embrace that important role and actively reinsert themselves as the historical community hub. Opportunities to do so range from offering cooking and nutrition classes to helping landlords attract complementary tenants so busy shoppers can order their nonperishable online, attend a workout class or other activity, and afterward spend a few minutes picking out their fruits and veggies.
Honest packaging
Grab a box of Cascadian Farms granola and I challenge you to squeeze it, wherever you want, without pressing against the contents. Unlike the traditional cereal offerings, which are in huge packages, but only half full, most consumers want quality ingredients in sustainable packaging.
Bio friendly packaging
Speaking of sustainable footprint, major improvements in packaging materials will be the next wave of consumer interest. Companies such as Coca-Cola have been introducing bioplastics into their production process for a few years, with the ultimate goal being a 100% bioplastic. Industry rival PepsiCo has also experimented with edible packaging options. The “plant” bottle should be a huge improvement by reduce its environmental impact and, hopefully, reduce the negative health effects of BPAs and other toxins related to common modern packaging.
Instead of food inflation through loss of quality, it’s time that the grocers get in line with today’s trends.
For more information and our full disclosure please visit http://www.stockcomm.com/ltmp
DISCLAIMER: Stock Communications Group, Inc (SCG) is a third-party publisher and news dissemination service provider that produces regular sponsored and non-sponsored reports, articles, stock market blogs, and newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SCG is NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and SCG ‘s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. SCG has been compensated for the coverage of Alltemp and owns restricted shares. SCG also expects to receive cash compensation during the course of the agreement from a third party non affiliate, to cover some of the expenses
The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and based on publicly available information which is believed to be reliable. The included information is subject to change without notice. SCG is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks.
This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and MSC undertakes no obligation to update such statements.
NetworkNewsWire (NNW) Third-Party Content
The above article is Third-Party Content and the NNW website may contain additional Third-Party Content articles and other content submitted by third parties, including articles submitted through the NNW Premium Partnership Program. All opinions, statements and representations expressed by such third parties are theirs alone and do not express or represent the views and opinions of NNW or its affiliates and owners. Content created by third parties is the sole responsibility of such third parties, and NNW does not endorse, guarantee or make representations concerning the accuracy and completeness of all third-party content. You acknowledge that by NNW providing you with this internet portal that makes accessible to you the ability to view third-party content through the NNW site, NNW does not undertake any obligation to you as a reader of such content or assume any liability relating to such third-party content. NNW expressly disclaims liability relating to such third-party content. NNW and its members, affiliates, successors, assigns, officers, directors, and partners assume no responsibility or liability that may arise from the third-party content, including, but not limited to, responsibility or liability for claims for defamation, libel, slander, infringement, invasion of privacy and publicity rights, fraud, or misrepresentation, or an private right of action under the federal securities laws of the United States or common law. Notwithstanding the foregoing, NNW reserves the right to remove third-party content at any time in its sole discretion. By viewing this third-party content, you acknowledge that you have viewed, read fully, accepted and agreed to all terms of the Disclaimer at http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
http://envirotechstock.com/
Report on Alltemp (LTMP) from Access Wallstreet. Don't know what the value of this report is (Publisher has been paid to make the report), but one can not deny that the future of the product is very bright !
Case study real results
APPLIED RESEARCH LABORATORIES – AHRI 210/240 ALLTEMP-L AND M-4
Chuck e Cheese’s – 12 Ton Carrier RTU 33% savings
Macy's – 30 Ton Carrier RTU 24% savings
Plastic Components – 25 ton Advantage Chiller 34% savings
McDonald’s – 10 Ton York RTU - 28% savings
W Hotel – 10 Ton Carrier RTU - 22% savings
Fortune 50 Media Company – 4 Ton Carrier Split System 24% savings
Del Vista Towers – 100 Ton Multi Stack DX 33% savings
Verizon – 25 Ton Air Flow CRAC 27% savings
7-Eleven – 2hp Copeland scroll compressor 38% savings
Fortune 50 Telecom Provider – 25 ton Liebert CRAC 32% savings
If you have not looked at the current case studies, you need to check out what Alltemp has already done and what it's products offer. I'm waiting for a local distributor to use this stuff in my home AC and car.
https://alltempsolutions.net/results/
Followers
|
30
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1235
|
Created
|
02/08/10
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |